I feel for anyone still in red - yes I was sceptical too in the beginning - but they won me by over in the first year - I had a Swag of the .40/$4 shares to get options
options were pointless - but we’ve had 5-6 years to average down with all the good news and collaborations along the way they all said obvious things to me. I seriously started buying more about 3 - 3.5 years back on the collaborations opening up... after already tiling up at equivalent to $1.20 years ago
and I’m extremely happy - those still out of the money who have not averaged down will get there soon don’t sweat the the 5 cents
from .38 to 1.50 is a much larger jump than 1.50 to $4
this is a good deal it’s worth the market not understanding it - and up front it’s 1.6 million - it’s an astoundingly good price to secure it plus royalty in mid single digits - lots of room to move.
now back to the main game Paxalisib.
- Forums
- ASX - By Stock
- KZA
- Ann: Kazia Corporate Presentation
Ann: Kazia Corporate Presentation, page-27
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online